|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
23
|
|
pubmed:dateCreated |
2004-11-30
|
|
pubmed:abstractText |
Final results are presented from two consecutive European studies for patients with metastatic rhabdomyosarcoma (RMS) to identify prognostic variables and determine the value of high-dose chemotherapy (HDCT) in complete remission.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Dec
|
|
pubmed:issn |
0732-183X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
1
|
|
pubmed:volume |
22
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
4787-94
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:15570080-Adolescent,
pubmed-meshheading:15570080-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:15570080-Chemotherapy, Adjuvant,
pubmed-meshheading:15570080-Child,
pubmed-meshheading:15570080-Child, Preschool,
pubmed-meshheading:15570080-Clinical Trials as Topic,
pubmed-meshheading:15570080-Combined Modality Therapy,
pubmed-meshheading:15570080-Europe,
pubmed-meshheading:15570080-Female,
pubmed-meshheading:15570080-Humans,
pubmed-meshheading:15570080-Infant,
pubmed-meshheading:15570080-Male,
pubmed-meshheading:15570080-Multivariate Analysis,
pubmed-meshheading:15570080-Neoplasm Metastasis,
pubmed-meshheading:15570080-Neoplasm Staging,
pubmed-meshheading:15570080-Probability,
pubmed-meshheading:15570080-Prognosis,
pubmed-meshheading:15570080-Proportional Hazards Models,
pubmed-meshheading:15570080-Radiotherapy, Adjuvant,
pubmed-meshheading:15570080-Retrospective Studies,
pubmed-meshheading:15570080-Rhabdomyosarcoma,
pubmed-meshheading:15570080-Risk Assessment,
pubmed-meshheading:15570080-Soft Tissue Neoplasms,
pubmed-meshheading:15570080-Surgical Procedures, Operative,
pubmed-meshheading:15570080-Survival Analysis,
pubmed-meshheading:15570080-Treatment Outcome
|
|
pubmed:year |
2004
|
|
pubmed:articleTitle |
European intergroup studies (MMT4-89 and MMT4-91) on childhood metastatic rhabdomyosarcoma: final results and analysis of prognostic factors.
|
|
pubmed:affiliation |
University of Padova, Padova, Italy. modesto.carli@unipd.it
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|
